ARTICLE | Distillery Therapeutics
Therapeutics: CXC chemokine receptor 4 (CXCR4; NPY3R)
March 26, 2015 7:00 AM UTC
In vitro and rodent studies suggest a quinazoline-based CXCR4 antagonist could help prevent acute kidney injury (AKI). Chemical synthesis and in vitro testing of quinazoline analogs identified a lead ...